Skip to main content
. 2016 Sep 19;139(12):2698–2704. doi: 10.1002/ijc.30403

Figure 1.

Figure 1

Graphical representation of risk of T2DM by time on GnRH agonists, T2DM was defined by anti‐diabetic drug prescriptions: (a) Insulin, (b) Sulphonluurea or Metaformin, (c) Insulin, Sulphonylurea or Metformin. [Color figure can be viewed at wileyonlinelibrary.com.]